Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
Blood. 2018 Feb 15;131(7):808-817. doi: 10.1182/blood-2017-08-801449. Epub 2017 Dec 15.
HLA-DPB1 T-cell epitope (TCE) mismatching algorithm and rs9277534 SNP at the 3' untranslated region (3'UTR) in the HLA-DPB1 gene are key factors for transplant-related events in unrelated hematopoietic cell transplantation (UR-HCT). However, the association of these 2 mechanisms has not been elucidated. We analyzed 19 frequent HLA-DPB1 alleles derived from Japanese healthy subjects by next-generation sequencing of the entire HLA-DPB1 gene region and multi-SNP data of the HLA region in 1589 UR-HCT pairs. The risk of acute graft-versus-host disease (aGVHD) was analyzed in 1286 patients with single HLA-DPB1 mismatch UR-HCT. The phylogenetic tree constructed using the entire gene region demonstrated that HLA-DPB1 alleles were divided into 2 groups, HLA-DP2 and HLA-DP5. Although a phylogenetic relationship in the genomic region from exon 3 to 3'UTR (Ex3-3'UTR) obviously supported the division of HLA-DP2 and HLA-DP5 groups, which in exon 2 showed intermingling of HLA-DPB1 alleles in a non-HLA-DP2 and non-HLA-DP5-group manner. Multi-SNP data also showed 2 discriminative HLA-DPB1 groups according to Ex3-3'UTR. Risk of grade 2-4 aGVHD was significantly higher in patient HLA-DP5 group mismatch than patient HLA-DP2 group mismatch (hazard ratio, 1.28; = .005), regardless of donor mismatch HLA-DP group. Regarding TCE mismatch, increasing risk of aGVHD in patient HLA-DP5 group mismatch and TCE-nonpermissive mismatch were observed only in patients with TCE-permissive mismatch and patient HLA-DP2 group mismatch, respectively. Evolutionary analysis revealed that rs9277534 represented a highly conserved HLA-DPB1 Ex3-3'UTR region and may provoke aGVHD differently to TCE mismatching algorithm, reflecting exon 2 polymorphisms. These findings enrich our understanding of the mechanism of aGVHD in HLA-DPB1 mismatch UR-HCT.
HLA-DPB1 T 细胞表位 (TCE) 错配算法和 HLA-DPB1 基因 3' 非翻译区 (3'UTR) 中的 rs9277534SNP 是无关造血细胞移植 (UR-HCT) 中与移植相关事件的关键因素。然而,这两种机制的关联尚未阐明。我们通过对整个 HLA-DPB1 基因区域进行下一代测序和对 1589 对 UR-HCT 的 HLA 区域的多 SNP 数据,分析了来自日本健康受试者的 19 个常见 HLA-DPB1 等位基因。在 1286 例 HLA-DPB1 单错配 UR-HCT 患者中分析了急性移植物抗宿主病 (aGVHD) 的风险。使用整个基因区域构建的系统发育树表明,HLA-DPB1 等位基因分为 2 组,HLA-DP2 和 HLA-DP5。尽管从外显子 3 到 3'UTR(Ex3-3'UTR)的基因组区域的系统发育关系明显支持 HLA-DP2 和 HLA-DP5 组的划分,但在外显子 2 中,HLA-DPB1 等位基因以非 HLA-DP2 和非 HLA-DP5 组的方式混合。多 SNP 数据也根据 Ex3-3'UTR 显示了 2 个有区别的 HLA-DPB1 组。与患者 HLA-DP2 组错配相比,患者 HLA-DP5 组错配的 2-4 级 aGVHD 风险显著更高(风险比,1.28; =.005),而与供体错配 HLA-DP 组无关。关于 TCE 错配,仅在 TCE 允许错配和患者 HLA-DP2 组错配的患者中观察到患者 HLA-DP5 组错配和 TCE 非允许错配的 aGVHD 风险增加。进化分析表明,rs9277534 代表高度保守的 HLA-DPB1 Ex3-3'UTR 区域,与 TCE 错配算法不同,可能引发 aGVHD,反映了外显子 2 多态性。这些发现丰富了我们对 HLA-DPB1 错配 UR-HCT 中 aGVHD 机制的理解。